Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 15/20 | 0.58 |
| ▸ | DRD2 | P14416 | 14/20 | 0.58 |
| ▸ | HTR2B | P41595 | 5/20 | 0.58 |
| ▸ | HTR2A | P28223 | 4/20 | 0.58 |
| ▸ | HTR1A | P08908 | 4/20 | 0.46 |
| ▸ | VPS4B | O75351 | 1/20 | 0.46 |
| ▸ | VCP | P55072 | 1/20 | 0.46 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4906206 | 1.00 | SLC6A4 (0.58) | SLC6A4DRD2HTR2BHTR2AHTR1A | |
| SCHEMBL4894593 | 0.94 | SLC6A4 (0.58) | SLC6A4DRD2HTR2BHTR2AHTR1A | |
| SCHEMBL4903878 | 0.94 | SLC6A4 (0.58) | SLC6A4DRD2HTR2BHTR2AHTR1A | |
| SCHEMBL4904405 | 0.90 | SLC6A4 (0.62) | SLC6A4DRD2HTR2BHTR2AHTR1A | |
| SCHEMBL4907059 | 0.90 | SLC6A4 (0.62) | SLC6A4DRD2HTR2BHTR2AHTR1A | |
| SCHEMBL4897995 | 0.90 | SLC6A4 (0.60) | SLC6A4DRD2HTR2BHTR2AHTR1A | |
| SCHEMBL4902811 | 0.90 | SLC6A4 (0.60) | SLC6A4DRD2HTR2BHTR2AHTR1A | |
| SCHEMBL4899330 | 0.90 | SLC6A4 (0.60) | SLC6A4DRD2HTR2BHTR2AHTR1A | |
| SCHEMBL4904454 | 0.90 | SLC6A4 (0.60) | SLC6A4DRD2HTR2BHTR2AHTR1A | |
| Maleic Acid SCHEMBL4900020 | 0.85 | DRD2 (0.57) | SLC6A4DRD2HTR2BHTR2AHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7297704-B2 | Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives | WYETH (US) | 2007-11-20 | — | — | US | claimed |
| US-20060205759-A1 | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives | WYETH (US) | 2006-09-14 | — | — | US | claimed |
| US-20080081910-A1 | CYCLOALKYLFUSED INDOLE, BENZOTHIOPHENE, BENZOFURAN AND INDENE DERIVATIVES | WYETH (US) | 2008-04-03 | — | — | US | disclosed |
| EP-1856126-A2 | CYCLOALKYLFUSED INDOLE, BENZOTHIOPHENE, BENZOFURAN AND INDENE DERIVATIVES | Wyeth a Corporation of the State of Delaware (US) | 2007-11-21 | — | — | EP | disclosed |
| US-7297704-B2 | Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives | WYETH (US) | 2007-11-20 | — | — | US | disclosed |
| US-20060205759-A1 | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives | WYETH (US) | 2006-09-14 | — | — | US | disclosed |
| WO-2006089053-A2 | CYCLOALKYLFUSED INDOLE, BENZOTHIOPHENE, BENZOFURAN AND INDENE DERIVATIVES | WYETH (US) | 2006-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205759-A1 | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives | TPH1, TPH2, HTR2C | SLC6A4 25/4885DRD2 147/4885HTR2B 16/4885 |
| US-20080081910-A1 | CYCLOALKYLFUSED INDOLE, BENZOTHIOPHENE, BENZOFURAN AND INDENE DERIVATIVES | TPH1, TPH2, HTR2C | SLC6A4 25/4885DRD2 147/4885HTR2B 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.